background image

Press Releases

Sep 13, 2021

Day One Appoints Jaa Roberson as Chief People Officer

Read more...

Aug 17, 2021

Day One Appoints Scott Garland to Board of Directors

Read more...

Aug 10, 2021

Day One Reports Second Quarter 2021 Financial Results and Corporate Progress

Read more...

Aug 04, 2021

Day One Biopharmaceuticals to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference

Read more...

Jul 27, 2021

Day One Receives FDA Rare Pediatric Disease Designation for DAY101 for the Treatment of Pediatric Low-Grade Glioma

Read more...

Jun 21, 2021

Day One Receives Orphan Designation from the European Commission for DAY101 for the Treatment of Glioma

Read more...

Jun 01, 2021

Day One Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Read more...

May 26, 2021

Day One Announces Pricing of Upsized Initial Public Offering

Read more...

May 11, 2021

Day One Announces First Patient Dosed in FIREFLY-1 Pivotal Phase 2 Clinical Trial of DAY101 in Pediatric Progressive Low-Grade Glioma

Read more...

Apr 12, 2021

Day One Appoints Saira Ramasastry to Board of Directors

Read more...
Displaying 1 - 10 of 13